314 related articles for article (PubMed ID: 26298074)
1. Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population.
Garg S; de Lemos JA; Ayers C; Khouri MG; Pandey A; Berry JD; Peshock RM; Drazner MH
JACC Cardiovasc Imaging; 2015 Sep; 8(9):1034-1041. PubMed ID: 26298074
[TBL] [Abstract][Full Text] [Related]
2. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
[TBL] [Abstract][Full Text] [Related]
3. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study.
Khouri MG; Peshock RM; Ayers CR; de Lemos JA; Drazner MH
Circ Cardiovasc Imaging; 2010 Mar; 3(2):164-71. PubMed ID: 20061518
[TBL] [Abstract][Full Text] [Related]
4. Estimate of ischemic stroke prevalence according to a novel 4-tiered classification of left ventricular hypertrophy: insights from the general Chinese population.
Wang H; Wang S; Yi X; Tao Y; Qian H; Jia P; Chen Y; Sun Y
Ann Med; 2018 Sep; 50(6):519-528. PubMed ID: 30001637
[TBL] [Abstract][Full Text] [Related]
5. Impact of Chamber Dilatation on the Prognostic Value of Left Ventricular Geometry in Hypertension.
Verdecchia P; Angeli F; Mazzotta G; Bartolini C; Garofoli M; Aita A; Poltronieri C; Pinzagli MG; Valecchi F; Martone S; Ramundo E; Turturiello D; Reboldi G
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28539381
[TBL] [Abstract][Full Text] [Related]
6. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
[TBL] [Abstract][Full Text] [Related]
7. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
8. Subclassification of left ventricular hypertrophy based on dilation stratifies coronary artery disease patients with distinct risk.
Huang BT; Peng Y; Liu W; Zhang C; Huang FY; Wang PJ; Zuo ZL; Liao YB; Chai H; Li Q; Zhao ZG; Luo XL; Ren X; Huang KS; Meng QT; Chen C; Huang DJ; Chen M
Eur J Clin Invest; 2014 Oct; 44(10):893-901. PubMed ID: 25104141
[TBL] [Abstract][Full Text] [Related]
9. Association of Concentric Left Ventricular Hypertrophy With Subsequent Change in Left Ventricular End-Diastolic Volume: The Dallas Heart Study.
Garg S; de Lemos JA; Matulevicius SA; Ayers C; Pandey A; Neeland IJ; Berry JD; McColl R; Maroules C; Peshock RM; Drazner MH
Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28775115
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular dilation and incident congestive heart failure in asymptomatic adults without cardiovascular disease: multi-ethnic study of atherosclerosis (MESA).
Yeboah J; Bluemke DA; Hundley WG; Rodriguez CJ; Lima JA; Herrington DM
J Card Fail; 2014 Dec; 20(12):905-11. PubMed ID: 25225112
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
12. Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: the Pamela study.
Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
J Hypertens; 2015 Oct; 33(10):2133-40. PubMed ID: 26196652
[TBL] [Abstract][Full Text] [Related]
13. Prognostic superiority of global longitudinal strain beyond four-tiered ventricular hypertrophy in asymptomatic individuals.
Sung KT; Chen YH; Kuo JY; Lai YH; Lo CI; Huang WH; Chien SC; Liu LY; Bulwer B; Hou CJ; Su CH; Hung TC; Hung CL; Yeh HI
J Formos Med Assoc; 2022 Aug; 121(8):1414-1424. PubMed ID: 34688532
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic left ventricular geometry profiles for prediction of stroke, coronary heart disease and all-cause mortality in the Chinese community: a rural cohort population study.
Li T; Li G; Guo X; Li Z; Sun Y
BMC Cardiovasc Disord; 2021 May; 21(1):238. PubMed ID: 33980151
[TBL] [Abstract][Full Text] [Related]
15. Left Ventricular Structure and Risk of Cardiovascular Events: A Framingham Heart Study Cardiac Magnetic Resonance Study.
Tsao CW; Gona PN; Salton CJ; Chuang ML; Levy D; Manning WJ; O'Donnell CJ
J Am Heart Assoc; 2015 Sep; 4(9):e002188. PubMed ID: 26374295
[TBL] [Abstract][Full Text] [Related]
16. Association of African Ancestry With Electrocardiographic Voltage and Concentric Left Ventricular Hypertrophy: The Dallas Heart Study.
Alame AJ; Garg S; Kozlitina J; Ayers C; Peshock RM; Matulevicius SA; Drazner MH
JAMA Cardiol; 2018 Dec; 3(12):1167-1173. PubMed ID: 30427995
[TBL] [Abstract][Full Text] [Related]
17. Association of myocardial deformation with mortality independent of myocardial ischemia and left ventricular hypertrophy.
Stanton T; Ingul CB; Hare JL; Leano R; Marwick TH
JACC Cardiovasc Imaging; 2009 Jul; 2(7):793-801. PubMed ID: 19608127
[TBL] [Abstract][Full Text] [Related]
18. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
Okin PM
J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.
Oseni AO; Qureshi WT; Almahmoud MF; Bertoni AG; Bluemke DA; Hundley WG; Lima JA; Herrington DM; Soliman EZ
Heart; 2017 Jan; 103(1):49-54. PubMed ID: 27486144
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of combined target-organ damage in patients with essential hypertension.
Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
